410 related articles for article (PubMed ID: 29327101)
1. Fundamentals of siRNA and miRNA therapeutics and a review of targeted nanoparticle delivery systems in breast cancer.
Ahmadzada T; Reid G; McKenzie DR
Biophys Rev; 2018 Feb; 10(1):69-86. PubMed ID: 29327101
[TBL] [Abstract][Full Text] [Related]
2. Efficient nanocarriers of siRNA therapeutics for cancer treatment.
Subhan MA; Torchilin VP
Transl Res; 2019 Dec; 214():62-91. PubMed ID: 31369717
[TBL] [Abstract][Full Text] [Related]
3. Cationic liquid crystalline nanoparticles for the delivery of synthetic RNAi-based therapeutics.
Gentile E; Oba T; Lin J; Shao R; Meng F; Cao X; Lin HY; Mourad M; Pataer A; Baladandayuthapani V; Cai D; Roth JA; Ji L
Oncotarget; 2017 Jul; 8(29):48222-48239. PubMed ID: 28637023
[TBL] [Abstract][Full Text] [Related]
4. RNAi-based therapeutics and tumor targeted delivery in cancer.
Kara G; Calin GA; Ozpolat B
Adv Drug Deliv Rev; 2022 Mar; 182():114113. PubMed ID: 35063535
[TBL] [Abstract][Full Text] [Related]
5. Lipid nanocarriers for microRNA delivery.
Scheideler M; Vidakovic I; Prassl R
Chem Phys Lipids; 2020 Jan; 226():104837. PubMed ID: 31689410
[TBL] [Abstract][Full Text] [Related]
6. Novel approaches in cancer treatment: preclinical and clinical development of small non-coding RNA therapeutics.
Cuciniello R; Filosa S; Crispi S
J Exp Clin Cancer Res; 2021 Dec; 40(1):383. PubMed ID: 34863235
[TBL] [Abstract][Full Text] [Related]
7. Versatile RNA interference nanoplatform for systemic delivery of RNAs.
Choi KY; Silvestre OF; Huang X; Min KH; Howard GP; Hida N; Jin AJ; Carvajal N; Lee SW; Hong JI; Chen X
ACS Nano; 2014 May; 8(5):4559-70. PubMed ID: 24779637
[TBL] [Abstract][Full Text] [Related]
8. Lipid Nanoparticle Technology for Clinical Translation of siRNA Therapeutics.
Kulkarni JA; Witzigmann D; Chen S; Cullis PR; van der Meel R
Acc Chem Res; 2019 Sep; 52(9):2435-2444. PubMed ID: 31397996
[TBL] [Abstract][Full Text] [Related]
9. Nanoparticles for targeted delivery of therapeutics and small interfering RNAs in hepatocellular carcinoma.
Varshosaz J; Farzan M
World J Gastroenterol; 2015 Nov; 21(42):12022-41. PubMed ID: 26576089
[TBL] [Abstract][Full Text] [Related]
10. A paradigm shift for extracellular vesicles as small RNA carriers: from cellular waste elimination to therapeutic applications.
Hagiwara K; Ochiya T; Kosaka N
Drug Deliv Transl Res; 2014; 4(1):31-7. PubMed ID: 24533256
[TBL] [Abstract][Full Text] [Related]
11. RNAi-Based Therapeutics and Novel RNA Bioengineering Technologies.
Traber GM; Yu AM
J Pharmacol Exp Ther; 2023 Jan; 384(1):133-154. PubMed ID: 35680378
[TBL] [Abstract][Full Text] [Related]
12. Endosomolytic and Tumor-Penetrating Mesoporous Silica Nanoparticles for siRNA/miRNA Combination Cancer Therapy.
Wang Y; Xie Y; Kilchrist KV; Li J; Duvall CL; Oupický D
ACS Appl Mater Interfaces; 2020 Jan; 12(4):4308-4322. PubMed ID: 31939276
[TBL] [Abstract][Full Text] [Related]
13. Nanovehicle-based Small Interfering RNA (siRNA) Delivery for Therapeutic Purposes: A New Molecular Approach in Pharmacogenomics.
Akhtari J; Tafazoli A; Mehrad-Majd H; Mahrooz A
Curr Clin Pharmacol; 2018; 13(3):173-182. PubMed ID: 29992895
[TBL] [Abstract][Full Text] [Related]
14. Small interfering RNAs based therapies for intracerebral hemorrhage: challenges and progress in drug delivery systems.
Almarghalani DA; Boddu SHS; Ali M; Kondaka A; Ta D; Shah RA; Shah ZA
Neural Regen Res; 2022 Aug; 17(8):1717-1725. PubMed ID: 35017419
[TBL] [Abstract][Full Text] [Related]
15. Effective tools for RNA-derived therapeutics: siRNA interference or miRNA mimicry.
Wang P; Zhou Y; Richards AM
Theranostics; 2021; 11(18):8771-8796. PubMed ID: 34522211
[TBL] [Abstract][Full Text] [Related]
16. Current development of targeted oligonucleotide-based cancer therapies: Perspective on HER2-positive breast cancer treatment.
Ngamcherdtrakul W; Castro DJ; Gu S; Morry J; Reda M; Gray JW; Yantasee W
Cancer Treat Rev; 2016 Apr; 45():19-29. PubMed ID: 26930249
[TBL] [Abstract][Full Text] [Related]
17. Folate Receptor-Mediated siRNA Delivery: Recent Developments and Future Directions for RNAi Therapeutics.
Gangopadhyay S; Nikam RR; Gore KR
Nucleic Acid Ther; 2021 Aug; 31(4):245-270. PubMed ID: 33595381
[TBL] [Abstract][Full Text] [Related]
18. Progress in microRNA delivery.
Zhang Y; Wang Z; Gemeinhart RA
J Control Release; 2013 Dec; 172(3):962-74. PubMed ID: 24075926
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]